Related Experiment Videos
Engineered zinc finger proteins for controlling stem cell fate
Victor V Bartsevich1, Jeffrey C Miller, Casey C Case
1Sangamo BioSciences, Inc., Point Richmond Tech Center, Richmond, California 94804, USA. victorb@sangamo.com
Stem Cells (Dayton, Ohio)
|November 5, 2003
Summary
Synthetic transcription factors successfully induced differentiation in embryonic stem cells by targeting the Oct-4 gene. This research demonstrates the potential of engineered transcription factors for controlling stem cell fate and gene expression.
Area of Science:
- Stem cell biology
- Molecular and cellular biology
- Synthetic biology
Background:
- Stem cells are defined by self-renewal and differentiation capabilities, crucial for development and tissue repair.
- Gene expression regulation, particularly of transcription factors, governs stem cell transitions.
- Modulating gene expression offers potential therapeutic strategies for stem cell applications.
Purpose of the Study:
- To investigate the efficacy of synthetic zinc finger protein transcription factors (ZFP-TFs) in inducing embryonic stem (ES) cell differentiation.
- To assess the ability of ZFP-TFs to target and modulate the Oct-4 gene, a key regulator of pluripotency.
Main Methods:
- Design and construction of ZFP-TFs specifically targeting the mouse Oct-4 gene.
- Evaluation of ZFP-TF-mediated transcriptional regulation of Oct-4.
- Analysis of downstream gene expression changes and ES cell differentiation induction.
Main Results:
- Engineered ZFP-TFs successfully targeted and regulated the transcription of the Oct-4 gene in ES cells.
- Modulation of Oct-4 expression by ZFP-TFs led to alterations in downstream gene expression patterns.
- These changes effectively induced differentiation in the targeted embryonic stem cells.
Conclusions:
- Synthetic ZFP-TFs can effectively control gene expression, specifically targeting Oct-4.
- This targeted gene regulation by ZFP-TFs drives embryonic stem cell differentiation.
- The findings highlight the therapeutic potential of engineered transcription factors in stem cell research.